Silly me: I thought this work included a retrospective assessment of the responders to identify biomarkers. People who responded well to A2-73 could then be assessed further and their genetic/biome information developed from such studies. Simply put such precision medicine work presented an alternative to getting people w/AD in a room, treating them and waiting w/o any real causal relation ship in mind.
Market Data 
Markets 
